SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Björn Jobke, Petar Milovanovic, Michael Amling, Björn Busse, Bisphosphonate-osteoclasts: Changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients, Bone, 2014, 59, 37

    CrossRef

  2. 2
    Sarah D. Berry, Robert R. McLean, Marian T. Hannan, L. Adrienne Cupples, Douglas P. Kiel, Changes in Bone Mineral Density May Predict the Risk of Fracture Differently in Older Adults According to Fall History, Journal of the American Geriatrics Society, 2014, 62, 12
  3. 3
    M. Tadrous, M. M. Mamdani, D. N. Juurlink, M. D. Krahn, L. E. Lévesque, S. M. Cadarette, Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen, Osteoporosis International, 2014, 25, 11, 2671

    CrossRef

  4. 4
    Jean-Yves Reginster, Serge Ferrari, Peyman Hadji, Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene, Current Medical Research and Opinion, 2014, 30, 6, 1165

    CrossRef

  5. 5
    A. Parthan, M. Kruse, I. Agodoa, S. Silverman, E. Orwoll, Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective, Bone, 2014, 59, 105

    CrossRef

  6. 6
    R. Rizzoli, J. Branco, M.-L. Brandi, S. Boonen, O. Bruyère, P. Cacoub, C. Cooper, A. Diez-Perez, J. Duder, R. A. Fielding, N. C. Harvey, M. Hiligsmann, J. A. Kanis, J. Petermans, J. D. Ringe, Y. Tsouderos, J. Weinman, J.-Y. Reginster, Management of osteoporosis of the oldest old, Osteoporosis International, 2014, 25, 11, 2507

    CrossRef

  7. 7
    Y.-T. Li, H.-F. Cai, Z.-L. Zhang, Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials, Osteoporosis International, 2014,

    CrossRef

  8. 8
    Dima L. Diab, Nelson B. Watts, Diagnosis and Treatment of Osteoporosis in Older Adults, Endocrinology and Metabolism Clinics of North America, 2013, 42, 2, 305

    CrossRef

  9. 9
    J.-P. Devogelaer, P. Sambrook, D. M. Reid, S. Goemaere, S. Ish-Shalom, J. Collette, G. Su, C. Bucci-Rechtweg, P. Papanastasiou, J.-Y. Reginster, Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids, Rheumatology, 2013, 52, 6, 1058

    CrossRef

  10. 10
    Patricia Sieber, Patrizia Lardelli, Claude A. Kraenzlin, Marius E. Kraenzlin, Christian Meier, Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice, Clinical Drug Investigation, 2013, 33, 2, 117

    CrossRef

  11. 11
    Gustavo Duque, Osteoporosis in older persons: current pharmacotherapy and future directions, Expert Opinion on Pharmacotherapy, 2013, 14, 14, 1949

    CrossRef

  12. 12
    M. Gosch, C. Kammerlander, T. Roth, H. K. Doshi, R. W. Gasser, M. Blauth, Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention, Archives of Orthopaedic and Trauma Surgery, 2013, 133, 8, 1101

    CrossRef

  13. 13
    Rebecca L. Dunn, Matthew L. Bird, Susan E. Conway, Mark A. Stratton, Use of Bisphosphonates in Older Adults: How Long Is Long Enough?, The Consultant Pharmacist, 2013, 28, 1, 39

    CrossRef

  14. 14
    Karine Briot, Bernard Cortet, Thierry Thomas, Maurice Audran, Hubert Blain, Véronique Breuil, Laure Chapuis, Roland Chapurlat, Patrice Fardellone, Jean-Marc Feron, Jean-Bernard Gauvain, Pascal Guggenbuhl, Sami Kolta, Eric Lespessailles, Brigitte Letombe, Christian Marcelli, Philippe Orcel, Patrick Seret, Florence Trémollières, Christian Roux, 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, 2012, 79, 3, 304

    CrossRef

  15. 15
    Karine Briot, Bernard Cortet, Thierry Thomas, Maurice Audran, Hubert Blain, Véronique Breuil, Laure Chapuis, Roland Chapurlat, Patrice Fardellone, Jean-Marc Feron, Jean-Bernard Gauvain, Pascal Guggenbuhl, Sami Kolta, Eric Lespessailles, Brigitte Letombe, Christian Marcelli, Philippe Orcel, Patrick Seret, Florence Trémollières, Christian Roux, Actualisation 2012 des recommandations françaises du traitement médicamenteux de l’ostéoporose post-ménopausique, Revue du Rhumatisme, 2012, 79, 3, 264

    CrossRef

  16. 16
    Peyman Hadji, Matti Aapro, Luis Costa, Michael Gnant, Antiresorptive treatment options and bone health in cancer patients—safety profiles and clinical considerations, Cancer Treatment Reviews, 2012, 38, 6, 815

    CrossRef

  17. 17
    Richard H Lee, Cathleen Colón-Emeric, Effectiveness of osteoporosis therapy among frail, older adults: should we carry out more trials?, Aging Health, 2012, 8, 5, 461

    CrossRef

  18. 18
    J. Bernard Walsh, Willem F. Lems, Dimitrios Karras, Bente L. Langdahl, Osten Ljunggren, Astrid Fahrleitner-Pammer, Annabel Barrett, Gerald Rajzbaum, Franz Jakob, Fernando Marin, Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS), Calcified Tissue International, 2012, 90, 5, 373

    CrossRef

  19. 19
    Jun Zhang, Ran Wang, Yi-Lei Zhao, Xiao-Hui Sun, Hong-Xing Zhao, Lu Tan, De-Cai Chen, Xu Hai-Bin, Efficacy of intravenous zoledronic acid in the prevention and treatment of osteoporosis: A meta–analysis, Asian Pacific Journal of Tropical Medicine, 2012, 5, 9, 743

    CrossRef

  20. 20
    Susan L. Greenspan, Subashan Perera, David Nace, Kimberly S. Zukowski, Mary A. Ferchak, Carroll J. Lee, Smita Nayak, Neil M. Resnick, FRAX or Fiction: Determining Optimal Screening Strategies for Treatment of Osteoporosis in Residents in Long-Term Care Facilities, Journal of the American Geriatrics Society, 2012, 60, 4
  21. 21
    Jeffrey R. Curtis, Monika M. Safford, Management of Osteoporosis among the Elderly with Other Chronic Medical Conditions, Drugs & Aging, 2012, 29, 7, 549

    CrossRef

  22. 22
    M. Gosch, C. Kammerlander, K. Pils, M. Lechleitner, U. Benvenuti-Falger, T. Roth, B. Joosten-Gstrein, P. Pietschmann, Therapie der Osteoporose beim geriatrischen Patienten, Zeitschrift für Gerontologie und Geriatrie, 2012, 45, 5, 417

    CrossRef

  23. 23
    Charles A. Inderjeeth, Kien Chan, Kevin Kwan, Michelle Lai, Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments, Journal of Bone and Mineral Metabolism, 2012, 30, 5, 493

    CrossRef

  24. 24
    Orlaith Brennan, Oran D. Kennedy, T. Clive Lee, Susan M. Rackard, Fergal J. O'Brien, Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis, Journal of Orthopaedic Research, 2011, 29, 3
  25. 25
    Cristina Alonso-Bouzon, Gustavo Duque, Osteoporosis senil: una actualización, Revista Española de Geriatría y Gerontología, 2011, 46, 4, 223

    CrossRef

  26. 26
    Roger H Jay, Sarah L Marrinan, Osteoporosis treatment and the older patient, Reviews in Clinical Gerontology, 2011, 21, 03, 233

    CrossRef

  27. 27
    M. Gosch, T. Roth, C. Kammerlander, B. Joosten-Gstrein, U. Benvenuti-Falger, M. Blauth, M. Lechleitner, Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation, Zeitschrift für Gerontologie und Geriatrie, 2011, 44, 6, 381

    CrossRef

  28. 28
    Hai NIE, Chao PENG, Jie HAO, Zhen-ming HU, Hong AN, Zoledronic acid in preventing fractures in women with postmenopausal osteoporosis: a meta analysis, Academic Journal of Second Military Medical University, 2011, 31, 9, 985

    CrossRef

  29. 29
    Serge Ferrari, Ego Seeman, David Karasik, David G Little, Toshio Matsumoto, Clinical and basic research papers – April 2010, IBMS BoneKEy, 2010, 7, 4, 134

    CrossRef

  30. 30
    David M. Reid, Update on the Use of Zoledronic Acid in the Management of Osteoporosis, Current Osteoporosis Reports, 2010, 8, 3, 145

    CrossRef